← Leaderboards
Konrad Hermann Stopsack
Massachusetts General Hospital
$2,049,685
Attributed
$2,049,685
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $756.1K · FY2023–25$1M$750K$500K$250K$0
'23
'24
'25
Funding mix
By agency
NIH$2,049,685 · 1
By mechanism
R37$2,049,685 · 1
Top collaborators
No co-investigators on record.
Most similar at Massachusetts General Hospital
Same institution · by research overlap
- Leo L Cheng$11,540,322
- Aria F Olumi$5,702,955
- David E Fisher$28,420,496
- Bob S Carter$9,693,982
- Julie Joann Miller$981,757
Others in their field
Other Rising Stars on “Common Neoplasm”
- Yan Ji · Healthpartners Institute$5,300,768
- Jeff P Simko · Washington University$4,624,354
- Erin Marcotte · University Of Minnesota$4,360,951
- Gary G Schwartz · University Of North Dakota$4,000,000
- Xu Chen · University Of California, San Francisco$3,581,285
- Stuart Marcus · Sonalasense Inc$3,491,029
Research focus
Common NeoplasmAccelerationAdolescenceAfrican AncestryAdultAgingAfrican AmericanAndrogensBiobankBiostatistical MethodsBreast Cancer Risk FactorCancer DiagnosisCancer EpidemiologyCancer EtiologyCancer GenomicsCancer RiskCancer TypeCarcinogenesis MechanismCarcinogenicityCbioportalCellsCohortCohort StudiesCommunities
Grant awards (3)
Etiologic Heterogeneity Between Molecular Subtypes of Prostate Cancer$639,285
R37 · FY2025 · CA · contact PI
Etiologic Heterogeneity Between Molecular Subtypes of Prostate Cancer$654,340
R37 · FY2024 · CA · contact PI
Etiologic Heterogeneity Between Molecular Subtypes of Prostate Cancer$756,060
R37 · FY2023 · CA · contact PI